uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Siiltibcy
Authorised
Human
Details
EMA number
EMEA/H/C/006177
ATC code
V04CF
Authorisation
13 January 2025
Revision
2
EMA page
Therapeutic indication
Diagnosis of infection with Mycobacterium tuberculosis.
MeSH:
Tuberculosis;Diagnosis
Group:
Tuberculosis diagnostics
Special characteristics
Additional monitoring
Active substances
Mycobacterium tuberculosis derived antigens (rdESAT‑6 and rCFP‑10)
Marketing Authorisation Holder
Serum Life Science Europe GmbH
MAH
Timeline
Filter by authority:
EMA
Siiltibcy authorised
13 Jan 2025
authorised
regulatory
Siiltibcy | uMedical